SE425312B - Sett att framstella morfolinderivat - Google Patents

Sett att framstella morfolinderivat

Info

Publication number
SE425312B
SE425312B SE7505237A SE7505237A SE425312B SE 425312 B SE425312 B SE 425312B SE 7505237 A SE7505237 A SE 7505237A SE 7505237 A SE7505237 A SE 7505237A SE 425312 B SE425312 B SE 425312B
Authority
SE
Sweden
Prior art keywords
morpholine derivatives
make
make morpholine
derivatives
morpholine
Prior art date
Application number
SE7505237A
Other languages
English (en)
Other versions
SE7505237L (sv
Inventor
B J Mcloughlin
A J Guildford
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of SE7505237L publication Critical patent/SE7505237L/sv
Publication of SE425312B publication Critical patent/SE425312B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7505237A 1974-05-07 1975-05-06 Sett att framstella morfolinderivat SE425312B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2001374A GB1452701A (en) 1974-05-07 1974-05-07 Morpholine derivatives
JP2495676A JPS52139074A (en) 1974-05-07 1976-03-08 Morpholine derivative and mental version drug composition containing same

Publications (2)

Publication Number Publication Date
SE7505237L SE7505237L (sv) 1975-11-10
SE425312B true SE425312B (sv) 1982-09-20

Family

ID=26254367

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7505237A SE425312B (sv) 1974-05-07 1975-05-06 Sett att framstella morfolinderivat

Country Status (20)

Country Link
US (1) US4010266A (sv)
JP (2) JPS50154273A (sv)
AR (1) AR209436A1 (sv)
AT (1) AT344188B (sv)
BE (1) BE828822A (sv)
CA (1) CA1067075A (sv)
CH (2) CH610894A5 (sv)
DD (1) DD121641A5 (sv)
DE (1) DE2519101A1 (sv)
DK (1) DK198675A (sv)
FI (1) FI751344A (sv)
FR (1) FR2269953B1 (sv)
GB (1) GB1452701A (sv)
HK (1) HK5580A (sv)
IN (1) IN141021B (sv)
KE (1) KE3021A (sv)
LU (1) LU72408A1 (sv)
NL (1) NL7505140A (sv)
SE (1) SE425312B (sv)
ZA (1) ZA752388B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4088814A (en) * 1974-05-07 1978-05-09 Imperial Chemical Industries Limited Morpholine derivatives
JPS5266991U (sv) * 1975-11-13 1977-05-18
DE2731668A1 (de) * 1976-07-14 1978-01-19 Ici Ltd Appetitzuegler
IE50355B1 (en) * 1979-10-20 1986-04-02 Wyeth John & Brother Ltd Morpholine derivatives
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
US6048859A (en) 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
IL112778A0 (en) * 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
ATE287878T1 (de) * 1996-08-23 2005-02-15 Neurosearch As Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
AU9087301A (en) 2000-09-11 2002-03-26 Sepracor Inc Ligands for monoamine receptors and transporters, and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2255077A (en) * 1938-03-21 1941-09-09 Du Pont Film Mfg Corp Filter dyes for color photography

Also Published As

Publication number Publication date
DE2519101A1 (de) 1975-11-20
CH610894A5 (sv) 1979-05-15
FI751344A (sv) 1975-11-08
CA1067075A (en) 1979-11-27
ZA752388B (en) 1976-03-31
IN141021B (sv) 1977-01-08
AU8021575A (en) 1976-10-21
CH634569A5 (de) 1983-02-15
BE828822A (fr) 1975-11-07
GB1452701A (en) 1976-10-13
ATA341575A (de) 1977-11-15
NL7505140A (nl) 1975-11-11
JPS52139074A (en) 1977-11-19
KE3021A (en) 1980-03-14
AR209436A1 (es) 1977-04-29
LU72408A1 (sv) 1976-11-11
DK198675A (da) 1975-11-08
AT344188B (de) 1978-07-10
JPS50154273A (sv) 1975-12-12
FR2269953B1 (sv) 1978-10-06
DD121641A5 (sv) 1976-08-12
FR2269953A1 (sv) 1975-12-05
HK5580A (en) 1980-02-29
US4010266A (en) 1977-03-01
SE7505237L (sv) 1975-11-10

Similar Documents

Publication Publication Date Title
SE7512087L (sv) Sett att framstella vattensvellbar polyalkylenoxid
SE7506743L (sv) Sett att framstella bispidin- och bispidonderivat
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE425244B (sv) Sett att framstella 4-hydroxi-3-kinolin-karboxamidderivat
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE385889B (sv) Sett att framstella morfolinderivat
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE425312B (sv) Sett att framstella morfolinderivat
DK524175A (da) Bendiazepinderivater
SE7514087L (sv) Morfolinderivat
SE425850B (sv) Sett att framstella abietamidderivat.
SE431983B (sv) Sett att framstella 15-etylendioxiprostansyraderivat
SE427655B (sv) Sett att framstella abietamidderivat
SE428471B (sv) Sett att framstella imidazolderivat
SE419647B (sv) Sett att framstella tiazolisokinolinderivat
SE7509209L (sv) Sett att framstella nya kinolinderivat
CU34293A (es) Derivados acilicos
SE401184B (sv) Sett att framstella morfolinderivat
SE415252B (sv) Sett att framstella nya oxifenylbutazonderivat
SE7508779L (sv) Sett att framstella prostaninsyraderivat
SE420731B (sv) Sett att framstella 5-androsten-17-on-derivat
SE7508561L (sv) Sett att framstella alfa-azidobensylpenicillin
SE7414622L (sv) Fenylpyridinamiderivat
DK234475A (da) Amidinhydrazonderivater
SE420722B (sv) Sett att framstella benshydryloxi-alkylaminderivat